Psychemedics Market Cap 2010-2024 | PMD

Psychemedics market cap history and chart from 2010 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Psychemedics market cap as of January 10, 2025 is $0B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $0.022B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.257B 0.00
Quest Diagnostics (DGX) United States $16.849B 17.08
DaVita (DVA) United States $12.285B 15.89
Encompass Health (EHC) United States $9.254B 21.82
Chemed (CHE) United States $7.946B 24.42
Elanco Animal Health (ELAN) United States $5.957B 14.18
RadNet (RDNT) United States $5.193B 115.00
Option Care Health (OPCH) United States $3.863B 18.31
Amedisys (AMED) United States $2.977B 21.19
LifeStance Health (LFST) United States $2.889B 0.00
Addus HomeCare (ADUS) United States $2.253B 26.44
Astrana Health (ASTH) United States $1.811B 24.77
U.S Physical Therapy (USPH) United States $1.327B 34.87
Pennant (PNTG) United States $0.909B 36.75
Aveanna Healthcare Holdings (AVAH) United States $0.871B 0.00
Atai Life Sciences (ATAI) Germany $0.268B 0.00
Bioqual (BIOQ) United States $0.058B 0.00
Daxor (DXR) United States $0.037B 0.00
Ontrak (OTRK) United States $0.008B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00